Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xyloglucan + pea protein
- Development stage
- Unknown
- Lead developer
- Novintethical Pharma
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral, Topical
01
Overview
Xyloglucan + pea protein is a natural product combination developed by Devintec SAGL for the management of gastrointestinal and dermatological disorders. The combination consists of xyloglucan, a polysaccharide derived from tamarind seeds (*Tamarindus indica*), and pea protein from *Pisum sativum*. It functions as a mechanical barrier protector (a "bio-barrier") that coats mucosal and epithelial surfaces. This protective film prevents the adhesion and penetration of pathogens and allergens while promoting the restoration of tight junction proteins, including ZO-1, occludin, and claudin-1. Clinically, it is used for conditions such as atopic dermatitis, where it has shown efficacy comparable to low-potency corticosteroids, and for gastrointestinal issues like irritable bowel syndrome with diarrhea (IBS-D) and functional bloating. It is approved in Europe as a medical device for restoring intestinal barrier integrity.
- Brand names
- GelsectanXilaplus
- Other names
- XG-PPxyloglucan and pea protein
02
Targets
OCLN (Occludin)TJP1 (Tight junction protein 1 (ZO-1))CLDN1 (Tight junction protein claudin-1)
Beyond the preview
Go deeper on xyloglucan + pea protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xyloglucan + pea protein.